PIK3CB and cancer: The importance of PI3K in cancer was initially described in 1985 after it was implicated in association with polyoma middle‐T antigen, which is required for tumorigenesis in animals.3 Subsequent work has intimately characterized the PI3K signaling pathway, and demonstrated that upregulation of this complex pathway is central in the development of cancer.